GlassScriptPhysician profile
Fardowsa Idris
NPI 1609419225
$2,488.72
in general payments reported to CMS, 2019-2025
16 companies · $355 in 2025
The $355 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.43 · 2022: $16.75 · 2023: $1,720 · 2024: $299 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,277 · Food and Beverage: $1,096.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,277.20 |
| Food and Beverage | $1,096.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $1,464.10 | 2023 | Intracept |
| Nevro Corp. | $269.00 | 2023-2024 | Senza, Vyrsa V1 |
| Boston Scientific Corporation | $112.86 | 2025 | General - Pain Management, Intracept |
| Globus Medical, INC. | $112.54 | 2025 | Senza, Vyrsa V1 |
| Spr Therapeutics, INC | $86.85 | 2024-2025 | Sprint Pns System |
| Abbott Laboratories | $83.15 | 2021-2022 | |
| Pfizer INC. | $68.97 | 2023 | |
| Collegium Pharmaceutical, INC. | $67.79 | 2023 | Xtampza, Belbuca |
| Saluda Medical Americas, INC. | $47.53 | 2024-2025 | Evoke |
| Virtus Pharmaceuticals LLC | $33.33 | 2024 | Levorphanol Tartrate |
| Surgalign Spine Technologies, INC. | $32.03 | 2021 | |
| Abbvie INC. | $29.56 | 2023 | |
| Fidia Pharma USA INC. | $25.48 | 2025 | Hymovis |
| Vertex Pharmaceuticals Incorporated | $25.46 | 2025 | |
| Convatec INC. | $16.20 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $13.87 | 2023 | Emgality, Reyvow |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fardowsa Idris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.